Effect of ear drops in hearing loss
Phase 2
- Conditions
- Health Condition 1: H838- Other specified diseases of innerear
- Registration Number
- CTRI/2024/07/070351
- Lead Sponsor
- Dr Aparna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Mild to moderately hearing loss 15-55 dB (According to Goodman’s classification).
2.Patients with clinical features mentioned for Badhirya and Sensory Neural Hearing Loss irrespective of gender.
3.Patients with intact Tympanic membrane.
Exclusion Criteria
1.Patients of Sensory Neural Hearing Loss occurred due to infective and Auto immune diseases.
2.Patients with Conductive and Mixed deafness.
3.Patients with Aural Tumor’s, Polyps.
4.Hearing loss due to any systemic disorders.
5.Tympanic membrane perforation.
6.Middle and Inner ear pathology like Acoustic neuroma, Meniere’s disease.
7.Genetic Sensory Neural Hearing Loss.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Significant and clinically meaningful reduction of dB in Pure tone Audiometry before to after treatmentTimepoint: 14 days
- Secondary Outcome Measures
Name Time Method Changes in intensity of Tinnitus assessed through gradings <br/ ><br>ERSA questionnaire (EVALUATION OF THE IMPACT OF HEARING LOSS IN ADULTS), to assess quality of life before & after treatment <br/ ><br>Timepoint: 14 days